USD 6.93 billion
E-Clinical Trials Solutions or Suite or Technologies Market Size, Share, Growth Analysis, By Product(Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM)), By Delivery mode(On demand, on premises and Cloud-based), By Development phase(Phase I, Phase II, Phase III, Phase IV), By End-use(Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35G2097 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|Tables:
124
|Figures:
77
E-Clinical Trials Solutions or Suite or Technologies Market Insights
E-Clinical Trials Solutions or Suite or Technologies Market size was valued at USD 6.93 billion in 2019 and is poised to grow from USD 7.89 billion in 2023 to USD 21.8 billion by 2031, growing at a CAGR of 13.9% in the forecast period (2024-2031).
In the biopharmaceutical sector, the phrase “e-Clinical” refers to an electronic system for automating management that aims to take the place of manual, ad hoc, or paper-driven procedures. In the past, the term “eClinical” referred to any technological application employed during a clinical trial. E-Clinical solutions are used to manage the complete clinical trial process as well as the enormous amounts of data involved at different phases and from different sites. They support competent and exact clinical trial design, preparation, execution, and reporting, including participant information, trial and filing deadlines, and other crucial milestones.
In developed nations like the U.S., where clinical trials are subject to strict regulations, the market for eClinical solutions is expanding due in large part to the increased requirement for safety monitoring. For instance, the National Institutes of Health and the U.S. Department of Health and Human Services are encouraging the sharing of clinical data and tightening the criteria for registering clinical trials. One of the key factors driving the market for eClinical solutions is the soaring demand from pharmaceutical and biopharmaceutical businesses for software solutions for clinical trials. Additionally, expanding the end-user base for eClinical solutions and increased government funds to support trials are predicted to drive the market for these products throughout the study period.
US E-Clinical Trials Solutions or Suite or Technologies Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
On demand
Fastest Growth
On demand
Growth Rate
13.9% CAGR
E-Clinical Trials Solutions/Suite/Technologies Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
E-Clinical Trials Solutions or Suite or Technologies Market Segmental Analysis
Global E-Clinical Trials Solutions or Suite or Technologies Market is segmented based on Product, delivery mode, development phase, end-use and region. Based on product, the Market is segmented into Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM), Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, Electronic Trial Master File (eTMF). Based on the delivery mode, the market has been segmented into on demand, on premises and Cloud-base. Based on the development phase, the market has been segmented into Phase I, Phase II, Phase III, Phase IV. Based on end users the market is segmented into Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
E-Clinical Trials Solutions or Suite or Technologies Market Analysis by Delivery Mode
The web-hosted (on demand) segment dominated the market for eClinical solutions and accounted for the largest revenue share of over 74.1% in 2021. The segment’s prominence can be attributed to advantages including simplicity of use, usability, and minimal initial investment. Due to the ease with which web-hosted goods can be customised, providers are able to alter how information is presented to different user groups. These goods are more interoperable than others in their class. Throughout the predicted period, the category is positioned to hold its position.
The cloud-based segment is the fastest growing segment and anticipated to exhibit an exponential CAGR of 15.2% during the forecast period. A result of built-in capabilities including adaptability, high accessibility, low handling costs, and simple data backup. These systems make real-time data available, allowing users to act quickly and give high-quality data for risk-based monitoring. The demand for cloud-based solutions is expected to increase as a result of these related benefits.
E-Clinical Trials Solutions or Suite or Technologies Market Analysis by Development Phase
The phase III segment dominated the eClinical solutions market and accounted for the largest revenue share of over 53.1% in 2021. The segment is expanding as a result of the increasing need for clinical data management software to reduce overall costs and boost process effectiveness. The expansion of the market is being significantly accelerated by the rising number of medications that successfully complete phase III. Phase III entails evaluating a drug’s effectiveness on a group of more than 1,000 patients. The complexity of the study rises as the number of participants does, which fuels the demand for computer-based data management systems and accelerates the use of eClinical solutions.
The phase I segment is the fastest-growing segment and estimated to be the highest CAGR during the forecast period. Due to the great importance of these systems in predicting future results and excluding medication candidates with the lowest likelihood of success. The creation of novel medications is booming as a result of advancements in personalised medicine and biological modelling systems. The segment’s expansion is anticipated to be fueled by a significant number of phase I trials and a complicated management and analysis of data gathered during various research.
E-Clinical Trials Solutions/Suite/Technologies Market Size By Delivery mode, 2021-2028 (%)
To get detailed analysis on other segments, Request For Free Sample Report
E-Clinical Trials Solutions or Suite or Technologies Market Regional Insights
North America dominated the market for eClinical solutions and accounted for the largest revenue share of over 51% in 2021. A growing target population and the incidence of lifestyle-related illnesses like diabetes and heart problems are expected to boost market expansion. The region’s market is also being driven by the introduction of new products by suppliers of eClinical solutions and an increase in government incentives. Additionally, it is projected that the residence of notable players and the accessibility of sophisticated infrastructure will both amplify the growth of the regional market.
Asia Pacific, the market for eClinical solutions is fastest growing with highest CAGR at 15.45% over the forecast period. The demand for software solutions in the region is being fueled by the region’s high unmet medical requirements and the increased prevalence of key chronic diseases like cancer, cardiovascular problems, and infectious diseases. Due to their enormous patient populations and inexpensive costs, nations like China, India, Korea, and Japan are receiving an increasing number of trials. The adoption of eClinical solutions in these areas has therefore increased as a result of this outsourcing. Government funding for drug development and research, which is expected to increase throughout the forecast period, is one of the main drivers of the APAC market’s growth as an emerging country.
E-Clinical Trials Solutions/Suite/Technologies Market By Geography, 2021-2028
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
E-Clinical Trials Solutions or Suite or Technologies Market Dynamics
E-Clinical Trials Solutions or Suite or Technologies Market Drivers
Increasing Operational Costs and Regulatory requirements associated with Clinical Research Studies
- Personalized or gene-based disease management is becoming more and more popular in the field of medical research and novel drug therapy. In comparison to already available alternative therapies or medications, government reimbursement organisations, commercial insurers, and payers frequently demand novel drugs that have a better therapeutic value and greater efficacy. Additionally, by controlling the standard pricing of innovative pharmaceuticals, these payers are reducing manufacturing businesses’ profit margins. The eClinical solutions sector is concentrating on the development and marketing of software solutions that help speed up and efficiently complete clinical studies. Major pharmaceutical and biotech firms are implementing new business models to lower their overall research expenditures, which is anticipated to fuel demand for sophisticated and cutting-edge eClinical solutions.
E-Clinical Trials Solutions or Suite or Technologies Market Restraints
High Implementation Costs associated with EClinical Solutions
- In order to efficiently manage their clinical research data and information throughout the research lifecycle, researchers might use eClinical solutions. Many integrated eClinical solutions (like CTMS and CDMS) offer clinical researchers end-to-end solutions for all phases of clinical trial administration. The cost of these software solutions is extremely high and premium. With additional costs for technical support for cloud-based systems, the installation and upkeep of eClinical solutions run about USD 2 million. The high cost of advanced eClinical software solutions is predicted to prevent small and price-conscious end users from adopting it.
Request Free Customization of this report to help us to meet your business objectives.
E-Clinical Trials Solutions or Suite or Technologies Market Competitive Landscape
E-Clinical Trials Solutions/Suite/Technologies Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
E-Clinical Trials Solutions or Suite or Technologies Market Top Player's Company Profiles
-
Medidata Solutions, Inc.
-
BioClinica, Inc.
-
CRF Health
-
OmniComm Systems, Inc.
-
Merge Healthcare Incorporated
-
eResearch Technology, Inc.
-
DATATRAK International, Inc.
-
Bioclinica (Bioclinica Acuity)
-
Clinical Ink
-
Dassault Systèmes SE
-
MedNet Solutions, Inc.
-
ERT Clinical
-
ICON plc
-
ArisGlobal LLC
-
IBM Watson Health
-
PHT Corporation
-
Anju Software, Inc.
-
OpenClinica, LLC
E-Clinical Trials Solutions or Suite or Technologies Market Recent Developments
- In June 2021, Bayer AG announced the acquisition of Noria Therapeutics Inc. And PSMA Therapeutics Inc. Both radiotherapy companies are developing targeted therapeutic and imaging radiopharmaceuticals.
- In August 2021, GE Healthcare and NorthStar Medical Radioisotopes, LLC, a global innovator of radiopharmaceuticals, announced an exclusive agreement to manufacture and distribute iodine-123 (1 123) capsules in the U.S.
- In March 2021, GE Healthcare introduced StarGuide, a nuclear medicine system to improve patient outcomes in bone procedures, neurology, cardiology, oncology, and other medical specialties.
E-Clinical Trials Solutions or Suite or Technologies Key Market Trends
- A number of market participants launched new goods in this industry. The development of strong diagnostic radiopharmaceutical pipelines and the introduction of new products are results of the increasing demand for nuclear imaging. Additionally, a big population of people with chronic illnesses encourages companies to introduce innovative goods to the market worldwide. Several key market leaders have entered into agreements and partnerships for the development and commercial launches of diagnostic radiopharmaceuticals.
E-Clinical Trials Solutions or Suite or Technologies Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our E-Clinical Trials Solutions/Suite/Technologies Market analysis, among regions North America is expected to capture higher market share, the growth of the region is attributed to growing target population and the incidence of lifestyle-related illnesses like diabetes and heart problems are expected to boost market expansion. The US has emerged as a significant contributor to market growth in North America. In terms of deployment mode, the web-hosted segment dominates the marine hybrid propulsion market. This segment's leading position can be attributed to its advantages including simplicity of use, usability, and minimal initial investment. In terms of development mode, phase III led the market and is predicted to grow at the fastest rate.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 6.93 billion |
| Market size value in 2031 | USD 21.8 billion |
| Growth Rate | 13.9% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
| Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on E-Clinical Trials Solutions or Suite or Technologies Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on E-Clinical Trials Solutions or Suite or Technologies Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the E-Clinical Trials Solutions or Suite or Technologies Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the E-Clinical Trials Solutions or Suite or Technologies Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the E-Clinical Trials Solutions or Suite or Technologies Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the E-Clinical Trials Solutions or Suite or Technologies Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
E-Clinical Trials Solutions or Suite or Technologies Market Report Snapshots
- E-Clinical Trials Solutions or Suite or Technologies Companies
- E-Clinical Trials Solutions or Suite or Technologies Market Size
- E-Clinical Trials Solutions or Suite or Technologies Market Analysis
- E-Clinical Trials Solutions or Suite or Technologies Geographic Analysis
- E-Clinical Trials Solutions or Suite or Technologies Market News
USA (+1) 351-333-4748
